CytomX Therapeutics Inc.
CytomX Therapeutics is an oncology biopharma deploying its Probody conditional‑activation platform to create safer, tumor‑targeted ADCs, T‑cell engagers, and cytokines. Partnerships with Amgen, BMS, and Pfizer underpin a differentiated solid‑tumor pipeline poised for growth.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 119
- HQ: South San Francisco
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.